Related Experiment Video
Updated: May 27, 2026

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms
Published on: March 3, 2021
Pharmacologic management during therapeutic hypothermia
Kyle A Weant1, Stephanie N Baker
1Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, USA.
Insights
Therapeutic hypothermia shows promise in improving survival and neurological outcomes for out-of-hospital cardiac arrest patients. This therapy involves controlled cooling and rewarming, with specific pharmacologic management to minimize complications and enhance patient recovery.
Area of Science:
- Emergency Medicine
- Cardiology
- Neurology
Background:
- Out-of-hospital cardiac arrest (OHCA) has a high mortality rate, often exceeding 90%.
- Survivors of OHCA frequently experience significant neurological deficits, with over 50% suffering brain damage.
- Limited therapeutic options exist to improve outcomes for OHCA patients.
Purpose of the Study:
- To evaluate the effectiveness of therapeutic hypothermia in improving outcomes for OHCA survivors.
- To review the physiological effects and management strategies associated with therapeutic hypothermia.
Main Methods:
- Analysis of two landmark randomized controlled trials on therapeutic hypothermia post-OHCA.
- Examination of the physiological processes during cooling and rewarming phases.
- Review of pharmacologic interventions to support hypothermia therapy.
Main Results:
- Therapeutic hypothermia demonstrated significant improvements in both neurological outcomes and mortality rates in OHCA patients.
- Established protocols for cooling, rewarming, and pharmacologic management are crucial for efficacy.
Conclusions:
- Therapeutic hypothermia is a vital intervention for improving survival and neurological function after out-of-hospital cardiac arrest.
- Healthcare providers require comprehensive knowledge of hypothermia protocols, physiological responses, and pharmacologic adjuncts for optimal patient care.
Abstract:
Out-of-hospital cardiac arrest continues to be associated with high morbidity and mortality as the mortality rate has been documented to be as high as 90% in patients who experience the insult at home. For those who survive, more than 50% will have some form of brain damage. Despite the devastation of this event, therapeutic options for improving outcomes in this population are unfortunately limited. However, therapeutic hypothermia has been evaluated in 2 landmark randomized, controlled trials in patients who experienced an out-of-hospital cardiac arrest with the results showing an improvement in both neurologic outcomes and mortality. Providers must be familiar with the rationale behind the therapy, the physiological effects of the cooling and rewarming processes, and the pharmacologic management that aides in improved outcomes and minimizes complications.
Related Concept Videos
Decreased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Cardiopulmonary Resuscitation IV: Pharmacological Management
Thermoregulation
Increased Body Temperature
Homeostatic Imbalances in Body Temperature

